Shenzhen Capital Group Leads $28M Series B Round In Biotech Hrain Biotechnology
September 30, 2019 — 17:23 CST
This Data Is Locked!
This area is available only to Subscribers.
Shanghai-based oncotherapy-focused firm Hrain biotechnology Co., Ltd. announces on Monday that it raises RMB200 million (US$28 million) in a series B funding round led by... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
